TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cann Group ( (AU:CAN) ) has provided an update.
Cann Group Limited announced an update to a previous announcement, correcting a clerical error regarding the issue price of placement shares. The price was initially listed as AUD 0.015 but has been corrected to AUD 0.0115. This adjustment ensures accurate financial reporting and may impact investor perceptions and the company’s market positioning.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is a key player in the Australian market, providing cannabis-based therapies for various medical conditions.
YTD Price Performance: -71.79%
Average Trading Volume: 4,115,458
Technical Sentiment Signal: Sell
Current Market Cap: A$8.66M
See more data about CAN stock on TipRanks’ Stock Analysis page.